Skip to main content

Table 6 PostHoc test between time points

From: Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response

 

Estimated marginal means

p values

 

Time 1

Time 2

Time 3

Time 1 vs. 2

Time 1 vs. 3

Time 2 vs. 3

Subpopulation

Mean ± SD and 95% CI

CD3+ (abs.)

1798.0 ± 463.59

1652.0-1943.0

1733.0 ± 663.24

1581.0-1886.0

1723.0 ± 583.77

1573.0-1874.0

0.960

0.727

1.000

CD3/CD25+ (%)

9.87 ± 2.86

8.98–10.8

9.64 ± 3.95

8.73–10.6

11.4 ± 3.52

10.48–12.3

1.000

< 0.001

< 0.001

CD3/CD45RA (%)

41.9 ± 9.35

39.0-44.9

44.6 ± 13.08

41.5–47.6

41.3 ± 11.60

38,2-44.3

0.090

1.000

0.021

CD3/CD45RO (%)

32.2 ± 7.75

29.8–34.7

30.6 ± 10.58

28.1–33.0

31.3 ± 9.45

28.8–33.7

0.067

0.571

0.953

CD4+ (abs.)

994.0 ± 252.35

915.0-1073.0

987.0 ± 360.44

904.0-1071.0

970.0 ± 317.99

888.0-1052.0

1.000

1.000

1.000

CD8+ (abs.)

667.0 ± 236.54

593.0-742.0

628.0 ± 335.49

551.0-706.0

639.0 ± 296.49

562.0-715.0

0.564

0.967

1.000

CD19+ (abs.)

252.0 ± 126.49

213.0-292.0

242.0 ± 185.81

199.0-284.0

264.0 ± 162.07

222.0-306.0

1.000

1.000

1.000

Lymphocyte (abs.)

2420 ± 600

2240–2600

2330 ± 820

2150–2520

2310 ± 720

2130–2500

0.848

0.579

1.000

Naive B (%)

78.9 ± 8.66

76.3–81.6

80.0 ± 11.61

77.3–82.7

76.3 ± 10.37

73.6–79.0

1.000

0.107

0.010

NK cell (%)

12.6 ± 4.69

11.2–14.0

12.0 ± 6.37

10.5–13.4

12.1 ± 5.69

10.6–13.5

1.000

1.000

1.000

NKT cell (%)

5.30 ± 5.18

3.73–6.87

5.05 ± 6.93

3.43–6.66

6.74 ± 6.27

5.14–8.35

1.000

0.237

0.125

Switched B (%)

11.8 ± 6.23

9.91–13.7

13.1 ± 8.41

11.16-15.0

14.0 ± 7.48

12.08–15.9

0.611

0.093

1.000

  1. The subpopulations at all three timepoints tested simultaneously using the mixed model